BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 17644195)

  • 1. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery.
    Correll CC; McKittrick BA
    J Med Chem; 2014 Aug; 57(16):6887-96. PubMed ID: 24697360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.
    Shukla AK; Violin JD; Whalen EJ; Gesty-Palmer D; Shenoy SK; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9988-93. PubMed ID: 18621717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teaching old receptors new tricks: biasing seven-transmembrane receptors.
    Rajagopal S; Rajagopal K; Lefkowitz RJ
    Nat Rev Drug Discov; 2010 May; 9(5):373-86. PubMed ID: 20431569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways.
    Liu Y; Yang Y; Ward R; An S; Guo XX; Li W; Xu TR
    Biochem J; 2015 Sep; 470(2):155-67. PubMed ID: 26348905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
    Magnan R; Escrieut C; Gigoux V; De K; Clerc P; Niu F; Azema J; Masri B; Cordomi A; Baltas M; Tikhonova IG; Fourmy D
    J Am Chem Soc; 2013 Feb; 135(7):2560-73. PubMed ID: 23323542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
    Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).
    Xiao K; Sun J; Kim J; Rajagopal S; Zhai B; Villén J; Haas W; Kovacs JJ; Shukla AK; Hara MR; Hernandez M; Lachmann A; Zhao S; Lin Y; Cheng Y; Mizuno K; Ma'ayan A; Gygi SP; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15299-304. PubMed ID: 20686112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
    Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
    Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven-transmembrane receptor signaling through beta-arrestin.
    Shenoy SK; Lefkowitz RJ
    Sci STKE; 2005 Nov; 2005(308):cm10. PubMed ID: 16267056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrestins and protein ubiquitination.
    Kommaddi RP; Shenoy SK
    Prog Mol Biol Transl Sci; 2013; 118():175-204. PubMed ID: 23764054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying biased β-arrestin signaling.
    Kenakin T
    Handb Exp Pharmacol; 2014; 219():57-83. PubMed ID: 24292824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of β-arrestin recruitment to activated seven transmembrane receptors using enzyme complementation.
    Bassoni DL; Raab WJ; Achacoso PL; Loh CY; Wehrman TS
    Methods Mol Biol; 2012; 897():181-203. PubMed ID: 22674166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo veritas, the next frontier for functionally selective GPCR ligands.
    Beaulieu JM
    Methods; 2016 Jan; 92():64-71. PubMed ID: 26320830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the BRET 7TM receptor/beta-arrestin assay in drug discovery and screening.
    Heding A
    Expert Rev Mol Diagn; 2004 May; 4(3):403-11. PubMed ID: 15137906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
    Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
    Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
    Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
    J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrestin pathways as drug targets.
    Luttrell LM
    Prog Mol Biol Transl Sci; 2013; 118():469-97. PubMed ID: 23764065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.
    Rajagopal S; Kim J; Ahn S; Craig S; Lam CM; Gerard NP; Gerard C; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):628-32. PubMed ID: 20018651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.